Newsbenzinga
Eli Lilly CEO Says Foundayo Wins One-Third of New Oral GLP-1 Patients as Company Captures 70% of New Seniors: 'Growing Week on Week'
· Published
Article summary
Eli Lilly captures 70% of new senior GLP-1 patients after Medicare coverage, while Foundayo gains traction among oral GLP-1 users.
An excerpt from the original article.
Comments —
Loading comments…